Stay updated on Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.0%
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check25 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check54 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.SummaryDifference1%
- Check76 days agoChange DetectedSeveral links related to lymphoma and rare diseases have been removed, along with various clinical trial data fields and options for downloading study information.SummaryDifference2%
- Check83 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new resources related to lymphoma and clinical trials, while the previous version 2.12.1 has been removed.SummaryDifference2%
Stay in the know with updates to Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page.